TRxADE HEALTH, Inc. (MEDS)
$0.3511
-0.03 (-7.36%)
Rating:
Recommendation:
-
| Symbol | MEDS |
|---|---|
| Price | $0.3511 |
| Beta | 1.176 |
| Volume Avg. | 0.36M |
| Market Cap | 3.272M |
| Shares () | - |
| 52 Week Range | 0.271-3.47 |
| 1y Target Est | - |
| DCF Unlevered | MEDS DCF -> | |
|---|---|---|
| DCF Levered | MEDS LDCF -> | |
| ROE | -135.14% | Strong Sell |
| ROA | -71.04% | Strong Sell |
| Operating Margin | - | |
| Debt / Equity | 238.22% | Strong Buy |
| P/E | - | |
| P/B | 2.07 | Strong Buy |
Latest MEDS news
About
Download (Excel)Mr. Surendra K. Ajjarapu
Healthcare
Pharmaceutical Retailers
NASDAQ Capital Market
TRxADE HEALTH, Inc. operates as a health services IT company in the United States. The company focuses on digitalizing the retail pharmacy experience by optimizing drug procurement, prescription journey, and patient engagement. It operates the TRxADE drug procurement marketplace, which offers price transparency, purchasing capabilities, and other value-added services; and offers patient centric telehealth services under the Bonum Health brand name. The company was formerly known as Trxade Group, Inc. and changed its name to TRxADE HEALTH, Inc. in June 2021. TRxADE HEALTH, Inc. is based in Lutz, Florida.